FCCC LOGO Faculty Publications
Kulke MH , Shah MH , Benson AB , Bergsland E , Berlin JD , Blaszkowsky LS , Emerson L , Engstrom PF , Fanta P , Giordano T , Goldner WS , Halfdanarson TR , Heslin MJ , Kandeel F , Kunz PL , Kuvshinoff BV , Lieu C , Moley JF , Munene G , Pillarisetty VG , Saltz L , Sosa JA , Strosberg JR , Vauthey JN , Wolfgang C , Yao JC , Burns J , Freedman-Cass D
Neuroendocrine Tumors, Version 1.2015
J Natl Compr Canc Netw. 2015 Jan;13(1) :78-108
Back to previous list
Abstract
Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical Practice Guidelines in Oncology for Neuroendocrine Tumors discuss the diagnosis and management of both sporadic and hereditary NETs. This selection from the guidelines focuses on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus.
Notes
Kulke, Matthew H. Shah, Manisha H. Benson, Al B., III Bergsland, Emily Berlin, Jordan D. Blaszkowsky, Lawrence S. Emerson, Lyska Engstrom, Paul F. Fanta, Paul Giordano, Thomas Goldner, Whitney S. Halfdanarson, Thorvardur R. Heslin, Martin J. Kandeel, Fouad Kunz, Pamela L. Kuvshinoff, Boris W., II Lieu, Christopher Moley, Jeffery F. Munene, Gitonga Pillarisetty, Venu G. Saltz, Leonard Sosa, Julie Ann Strosberg, Jonathan R. Vauthey, Jean-Nicolas Wolfgang, Christopher Yao, James C. Burns, Jennifer Freedman-Cass, Deborah Practice Guideline J Natl Compr Canc Netw. 2015 Jan;13(1):78-108. doi: 10.6004/jnccn.2015.0011.